LEADER 01461nam  2200421   450 
001 9910704521303321
005 20130509081234.0
035   $a(CKB)5470000002442495
035   $a(OCoLC)842230861
035   $a(EXLCZ)995470000002442495
100   $a20130509d2013      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aEnd-stage renal disease $eCMS should improve design and strengthen monitoring of low-volume adjustment : report to congressional committees
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2013.
215   $a1 online resource (ii, 26 pages) $ccolor illustrations
300   $aTitle from title screen (viewed Apr. 25, 2013).
300   $a"March 2013."
300   $a"GAO-13-287."
320   $aIncludes bibliographical references.
517   $aEnd-stage renal disease 
606   $aMedicare$xEconomic aspects
606   $aMedicare$xClaims administration
606   $aHome hemodialysis$xCosts
606   $aChronic renal failure$xEconomic aspects
615  0$aMedicare$xEconomic aspects.
615  0$aMedicare$xClaims administration.
615  0$aHome hemodialysis$xCosts.
615  0$aChronic renal failure$xEconomic aspects.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910704521303321
996   $aEnd-stage renal disease$93440710
997   $aUNINA